Quinitles Phase I Services — Overland Park, Kansas

Quinitles Phase I Services is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Quinitles Phase I Services has participated in 1 clinical trials.

Therapeutic areas: Intervention for Nerve Agent Exposure.

Sponsors: PharmAthene, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quinitles Phase I Services?

Quinitles Phase I Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quinitles Phase I Services conducted?

Quinitles Phase I Services has 1 clinical trials on record. Their work covers Intervention for Nerve Agent Exposure.

Is Quinitles Phase I Services accredited by Crixeo Health?

Quinitles Phase I Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quinitles Phase I Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.